The parameters of the M-mode echocardiography at 16 weeks after the TAC operation also suggested that the TAC-induced progression from cardiac hypertrophy to heart failure was inhibited by the overexpression of tomoregulin-1 (data not shown, supplementary material Table S7). This evidence concerns the gene TMEFF1 and cardiac hypertrophy.